3315: Mistletoe Injections: The Cancer Therapy You Haven’t Heard About
March 4, 2025
3315: Mistletoe Injections: The Cancer Therapy You Haven’t Heard About
March 4, 2025
Cancer rates are at an all-time high…
And while conventional treatments continue to advance, there are natural therapies being widely used in other parts of the world that remain underutilized in the United States.
One such therapy is mistletoe extract, a plant-based treatment that has been shown to support immune function and improve quality of life in cancer patients.
So on today’s Cabral Concept 3315, I want to dive into the latest research on mistletoe therapy, its potential benefits, and what the science really says about its role in integrative cancer care. Enjoy the show, and let me know your thoughts!
Links From This Episode
Additional Research
- A 2016 meta-analysis of mistletoe therapy in advanced cancer patients (published in Cancer Medicine) found a statistically significant increase in overall survival for patients receiving mistletoe alongside conventional treatment.
- A study in BMC Complementary Medicine and Therapies (2020) reported that mistletoe therapy improved tumor regression rates in advanced pancreatic cancer patients.
- Another study in BMC Cancer (2018) showed that mistletoe treatment reduced neuropathy and chemotherapy-induced cognitive impairment ("chemo brain”).
- A 2016 study in PLoS One demonstrated that mistletoe extract caused apoptosis in pancreatic cancer cells by upregulating the caspase pathway, a key regulator of cell death.
- Another 2020 in-vitro study showed that mistletoe lectins suppressed tumor growth in breast and colon cancer cells by disrupting cancer cell metabolism.
- A 2013 systematic review in Evidence-Based Complementary and Alternative Medicine found that mistletoe therapy enhanced immune function in cancer patients, leading to improved quality of life.
- A 2014 study in Journal of Cancer Research and Clinical Oncology found that patients with stage IV lung cancer who received mistletoe therapy had significantly better symptom control and mood stability compared to those receiving conventional treatment alone.
